3001 DAIMLER ST,, SANTA ANA, CA
News, Material Contracts
News, Securities Holder Rights or Indentures, Material Contracts
Announces Completion of Acquisition; Gains Full Control of Global Manufacturing and Intellectual Property Assets
Enter Strategic Partnership to Bring Novel NK Cell Therapy to Japan
Announces New Funding to Regain Compliance with Reporting Obligations and Listing Standards
News
Chairman & CEO Paul Y. Song, M.D., Personally Invests $2.65 Million Cash to Accelerate Phase 2 Clinical Trial and Fulfill Financial Reporting Obligations
FY 2024
Notice of Late Filing for Annual Report
Q0
Notice of Late Filing for Quarterly Report
Q2
Q1
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Amended Registration Statement for Securities
S-1
Definitive Proxy Statement
PRE 14A
PRER14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload